An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? Published on 2020-05-292022-10-31 Journal: Frontiers in Pharmacology [키워드] COVID-19 Everolimus hyper-activation immune-regulation mTOR [저자] Giuseppe Terrazzano, Valentina Rubino, Anna Teresa Palatucci, Angela Giovazzino, Flavia Carriero, Giuseppina Ruggiero [Category] COVID-19, PMC URL [DOI] 10.3389/fphar.2020.00856 [Article Type] Pharmacology [Source] PMC All Keywords 【저자키워드】 COVID-19, immune-regulation, mTOR, hyper-activation, Everolimus,